Carlyle–SK Capital bid gains momentum as Bluebird backs deal amid growth plans - Private Equity Insights

Bluebird bio reaffirms Carlyle deal as Ayrmid misses deadline - Yahoo Finance

bluebird bio opts to stay with Carlyle/SK takeover offer - The Pharma Letter

Carlyle CEO Says Stickiness of Inflation Reflects Strong Economy - news.bloombergtax.com

Carlyle CEO Says Stickiness of Inflation Reflects Strong Economy - Bloomberg.com

Carlyle Group CEO Talks Fed, China-US and Trump Tariffs - Yahoo Finance

Carlyle wins long jump for B-U at Harry Green Invitational - My Buckhannon

Carlyle wrestlers bring home medals from provincials - SaskToday.ca

Carlyle Credit Income Fund Schedules Second Quarter Financial Results and Investor Conference Call - The Globe and Mail

bluebird bio's board opts for sale to U.S. investment firms - The Business Journals

The Carlyle Group (NASDAQ:CG) Price Target Cut to $44.00 by Analysts at Morgan Stanley - MarketBeat

Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal - Fierce Pharma

Bluebird Bio Says Ayrmid Failed To Submit Formal Offer, Confirms Carlyle, SK Deal; Stock Fell - Nasdaq

Carlyle Group Inc. Makes New Investment in StandardAero, Inc. (NYSE:SARO) - MarketBeat

Carlyle Group Inc. Has $18.76 Million Stock Holdings in Getty Images Holdings, Inc. (NYSE:GETY) - MarketBeat